BioSpace News Archive

PhotoPharmics, a pioneer in specialized phototherapy for neurodegenerative diseases, today announced a collaboration with the Center for Health + Technology (CHeT) at the University of Rochester Medical Center to conduct an at home, telemedicine, phase 3 trial to establish safety and efficacy for the company’s non-invasive specialized phototherapy device for Parkinson’s disease.

AccuReg, a healthcare technology solutions company, offers hospitals across the country a suite of price transparency solutions that will ensure they meet and exceed the new government compliance requirements that must be implemented by January 2021.

Syapse is building Asia’s premier learning health network of real-world data derived from leading precision cancercenters

Sixteen finalists are announced in the “Make Your Medical Device Pitch for Kids!” special COVID-19 edition competition presented by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI).

Prosperity Behavioral Health and Vertex Healthcare Services, two leading providers of financial services and solutions to the behavioral healthcare industry, announced today that they have merged.

While studying the effects of androgens on hair loss, Applied Biology scientists discovered an association between cellular receptors that predispose an individual to develop common hair loss (androgenetic alopecia) and COVID-19.

The special supplement examines strategies, best practices and technologies to make dentistry as safe as possible for clinicians and patients in the COVID-19 health care environment

Dr. George Sadowski, M.D., founder, and Chief Medical Officer for Nourishing Biologicals (NB), has published a revolutionary study, “Safety and Efficacy of a Novel Antiaging Skin Care Regimen Containing Nutraceuticals and Growth Factors on the Facial Skin of Women” in The Journal of Clinical and Aesthetic Dermatology.

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on improving the lives of patients who suffer from psychiatric disorders, announced that Keith J. Sullivan has been appointed as the company’s President and Chief Executive Officer and has joined the Board of Directors effective immediately. “The Neuronetics Board of Directors is very happy to complete our rigorous CEO search with the hiring of Keith Sulliva

Zynex, Inc. (“Zynex”) (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it is commencing an underwritten public offering of shares of its comm